AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...
The Register on MSN
Hobble your AI agents to prevent them from hurting you too badly
In short, to reduce the risk of AI agent exploitation, hobble your AI agents. Don't give them access to file deletion ...
3don MSN
4 Healthcare Stocks to Buy Now
As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.
First gentleman Denga Ndaitwah has cautioned that Namibia's Vision 2030 risks remaining an academic exercise if it is not aligned with the country's socio-economic realities and implemented with ...
Prominent players in the market are Givaudan, International Flavors & Fragrances (IFF), Symrise AG, Firmenich (DSM-Firmenich) ...
Nanjing Shiweng Technology Co., Ltd. applied for a patent titled "An Enterprise Intelligent Management System Based on Human-Machine Collaboration" in June 2025, with publication number CN120746172A.
Traditionally, chemical reactions have been described as one-line "equations" in which substrates, say A and B, convert purposefully but rigidly into ...
The Accountant on MSN
Australian accountants unwilling to replace roles with AI
Small accounting firms in Australia are turning to artificial intelligence to boost efficiency, but there is a lack of appetite for using AI to replace staff, according to BizCover’s Accounting Small ...
A San Francisco -based biotech company, backed by OpenAI ’s Sam Altman, has won government approval to begin clinical trials of a new “safer MDMA ”. The company, Arcadia Medicine, which is developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results